Therapeutic Prospects of Cannabidiol for Alcohol Use Disorder and Alcohol-Related Damages on the Liver and the Brain
出版年份 2019 全文链接
标题
Therapeutic Prospects of Cannabidiol for Alcohol Use Disorder and Alcohol-Related Damages on the Liver and the Brain
作者
关键词
-
出版物
Frontiers in Pharmacology
Volume 10, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2019-05-31
DOI
10.3389/fphar.2019.00627
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Structural insight into the serotonin (5-HT) receptor family by molecular docking, molecular dynamics simulation and systems pharmacology analysis
- (2019) Yuan-qiang Wang et al. ACTA PHARMACOLOGICA SINICA
- Cannabinoid CB1 receptors mediate the anxiolytic effects induced by systemic alprazolam and intra-periaqueductal gray 5-HT1A receptor activation
- (2019) Luara A. Batista et al. NEUROSCIENCE LETTERS
- Face validity of a pre-clinical model of operant binge drinking: just a question of speed
- (2018) Jérôme Jeanblanc et al. ADDICTION BIOLOGY
- Regional Brain Volume Changes in Alcohol-Dependent Individuals During Short-Term and Long-Term Abstinence
- (2018) Xiaowei Zou et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- Alcohol and Opioid Use, Co-Use, and Chronic Pain in the Context of the Opioid Epidemic: A Critical Review
- (2018) Katie Witkiewitz et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- Cannabidiol (CBD) as an Adjunctive Therapy in Schizophrenia: A Multicenter Randomized Controlled Trial
- (2018) Philip McGuire et al. AMERICAN JOURNAL OF PSYCHIATRY
- Effects of cannabidiol plus naltrexone on motivation and ethanol consumption
- (2018) Adrián Viudez-Martínez et al. BRITISH JOURNAL OF PHARMACOLOGY
- Allosteric and orthosteric pharmacology of cannabidiol and cannabidiol-dimethylheptyl at the type 1 and type 2 cannabinoid receptors
- (2018) Mylyne Tham et al. BRITISH JOURNAL OF PHARMACOLOGY
- EASL Clinical Practice Guidelines: Management of alcohol-related liver disease
- (2018) Mark Thursz et al. JOURNAL OF HEPATOLOGY
- Cannabis for paediatric epilepsy: challenges and conundrums
- (2018) Kerrie-Anne Chen et al. MEDICAL JOURNAL OF AUSTRALIA
- The anxiolytic effects of cannabidiol in chronically stressed mice are mediated by the endocannabinoid system: Role of neurogenesis and dendritic remodeling
- (2018) Manoela V. Fogaça et al. NEUROPHARMACOLOGY
- Unique treatment potential of cannabidiol for the prevention of relapse to drug use: preclinical proof of principle
- (2018) Gustavo Gonzalez-Cuevas et al. NEUROPSYCHOPHARMACOLOGY
- Cannabidiol presents an inverted U-shaped dose-response curve in a simulated public speaking test
- (2018) Ila M. Linares et al. REVISTA BRASILEIRA DE PSIQUIATRIA
- Serotonin receptors and suicide, major depression, alcohol use disorder and reported early life adversity
- (2018) Mark D. Underwood et al. Translational Psychiatry
- Pharmacotherapy of alcoholism – an update on approved and off-label medications
- (2017) Michael Soyka et al. EXPERT OPINION ON PHARMACOTHERAPY
- Modulation of Astrocyte Activity by Cannabidiol, a Nonpsychoactive Cannabinoid
- (2017) Ewa Kozela et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Cannabidiol disrupts the consolidation of specific and generalized fear memories via dorsal hippocampus CB 1 and CB 2 receptors
- (2017) Cristina A.J. Stern et al. NEUROPHARMACOLOGY
- The postnatal 5-HT 1A receptor regulates adult anxiety and depression differently via multiple molecules
- (2017) Chihiro Ishikawa et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Cannabidiol reduces neuroinflammation and promotes neuroplasticity and functional recovery after brain ischemia
- (2017) Marco Aurélio Mori et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Binding and Signaling Studies Disclose a Potential Allosteric Site for Cannabidiol in Cannabinoid CB2 Receptors
- (2017) Eva Martínez-Pinilla et al. Frontiers in Pharmacology
- Cannabidiol attenuates alcohol-induced liver steatosis, metabolic dysregulation, inflammation and neutrophil-mediated injury
- (2017) Yuping Wang et al. Scientific Reports
- A novel crosstalk within the endocannabinoid system controls GABA transmission in the striatum
- (2017) A. Musella et al. Scientific Reports
- Nalmefene for the management of alcohol dependence: review on its pharmacology, mechanism of action and meta-analysis on its clinical efficacy
- (2016) Karl Mann et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Cannabidiol Limits T Cell-Mediated Chronic Autoimmune Myocarditis: Implications to Autoimmune Disorders and Organ Transplantation
- (2016) Wen-Shin Lee et al. MOLECULAR MEDICINE
- Cannabidiol, neuroprotection and neuropsychiatric disorders
- (2016) Alline C. Campos et al. PHARMACOLOGICAL RESEARCH
- A Personal Retrospective: Elevating Anandamide (AEA) by Targeting Fatty Acid Amide Hydrolase (FAAH) and the Fatty Acid Binding Proteins (FABPs)
- (2016) Dale G. Deutsch Frontiers in Pharmacology
- Neuroimmune Interface in the Comorbidity between Alcohol Use Disorder and Major Depression
- (2016) Sudan Prasad Neupane Frontiers in Immunology
- Role of the endocannabinoid system in diabetes and diabetic complications
- (2015) G Gruden et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor
- (2015) R B Laprairie et al. BRITISH JOURNAL OF PHARMACOLOGY
- Pharmacotherapy for Alcohol Dependence: The 2015 Recommendations of the French Alcohol Society, Issued in Partnership with the European Federation of Addiction Societies
- (2015) Benjamin Rolland et al. CNS Neuroscience & Therapeutics
- Fatty Acid-binding Proteins (FABPs) Are Intracellular Carriers for Δ9-Tetrahydrocannabinol (THC) and Cannabidiol (CBD)
- (2015) Matthew W. Elmes et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Two non-psychoactive cannabinoids reduce intracellular lipid levels and inhibit hepatosteatosis
- (2015) Cristoforo Silvestri et al. JOURNAL OF HEPATOLOGY
- A systematic review of the antipsychotic properties of cannabidiol in humans
- (2015) Tabitha A. Iseger et al. SCHIZOPHRENIA RESEARCH
- The neuroprotection of cannabidiol against MPP + -induced toxicity in PC12 cells involves trkA receptors, upregulation of axonal and synaptic proteins, neuritogenesis, and might be relevant to Parkinson's disease
- (2015) Neife Aparecida Guinaim Santos et al. TOXICOLOGY IN VITRO
- Pharmacological activation of CB2 receptors counteracts the deleterious effect of ethanol on cell proliferation in the main neurogenic zones of the adult rat brain
- (2015) Patricia Rivera et al. Frontiers in Cellular Neuroscience
- Postdependent state in rats as a model for medication development in alcoholism
- (2014) Marcus W. Meinhardt et al. ADDICTION BIOLOGY
- Serial longitudinal magnetic resonance imaging data indicate non-linear regional gray matter volume recovery in abstinent alcohol-dependent individuals
- (2014) Timothy C. Durazzo et al. ADDICTION BIOLOGY
- Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders
- (2014) Orrin Devinsky et al. EPILEPSIA
- Acute and chronic administration of a low-dose combination of topiramate and ondansetron reduces ethanol’s reinforcing effects in male alcohol preferring (P) rats.
- (2014) Catherine F. Moore et al. EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY
- Cannabidiol protects liver from binge alcohol-induced steatosis by mechanisms including inhibition of oxidative stress and increase in autophagy
- (2014) Lili Yang et al. FREE RADICAL BIOLOGY AND MEDICINE
- Immunity and inflammatory signaling in alcoholic liver disease
- (2014) Pranoti Mandrekar et al. Hepatology International
- Determination of Genotype Combinations That Can Predict the Outcome of the Treatment of Alcohol Dependence Using the 5-HT3Antagonist Ondansetron
- (2013) Bankole A. Johnson et al. AMERICAN JOURNAL OF PSYCHIATRY
- The anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis: involvement of the endocannabinoid system
- (2013) Alline C. Campos et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Global burden of alcoholic liver diseases
- (2013) Jürgen Rehm et al. JOURNAL OF HEPATOLOGY
- Cannabidiol Normalizes Caspase 3, Synaptophysin, and Mitochondrial Fission Protein DNM1L Expression Levels in Rats with Brain Iron Overload: Implications for Neuroprotection
- (2013) Vanessa Kappel da Silva et al. MOLECULAR NEUROBIOLOGY
- Mechanisms of cannabidiol neuroprotection in hypoxic–ischemic newborn pigs: Role of 5HT1A and CB2 receptors
- (2013) M. Ruth Pazos et al. NEUROPHARMACOLOGY
- Widespread and sustained cognitive deficits in alcoholism: a meta-analysis
- (2012) Katherine Stavro et al. ADDICTION BIOLOGY
- Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid?
- (2012) Javier Fernández-Ruiz et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Cannabidiol as potential anticancer drug
- (2012) Paola Massi et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Is the cardiovascular system a therapeutic target for cannabidiol?
- (2012) Christopher P. Stanley et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia
- (2012) F M Leweke et al. Translational Psychiatry
- Alcohol and the Human Brain: A Systematic Review of Different Neuroimaging Methods
- (2011) Mira Bühler et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- Cannabidiol, a non-psychotropic component of cannabis, attenuates vomiting and nausea-like behaviour via indirect agonism of 5-HT1A somatodendritic autoreceptors in the dorsal raphe nucleus
- (2011) EM Rock et al. BRITISH JOURNAL OF PHARMACOLOGY
- Differential transcriptional profiles mediated by exposure to the cannabinoids cannabidiol and Δ9-tetrahydrocannabinol in BV-2 microglial cells
- (2011) Ana Juknat et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress
- (2011) George W. Booz FREE RADICAL BIOLOGY AND MEDICINE
- Cannabinoid CB2 receptors protect against alcoholic liver disease by regulating Kupffer cell polarization in mice
- (2011) Alexandre Louvet et al. HEPATOLOGY
- Cannabidiol Reduces the Anxiety Induced by Simulated Public Speaking in Treatment-Naïve Social Phobia Patients
- (2011) Mateus M Bergamaschi et al. NEUROPSYCHOPHARMACOLOGY
- Cannabidiol causes activated hepatic stellate cell death through a mechanism of endoplasmic reticulum stress-induced apoptosis
- (2011) M P Lim et al. Cell Death & Disease
- The effects of Δ9-tetrahydrocannabinol and cannabidiol alone and in combination on damage, inflammation andin vitromotility disturbances in rat colitis
- (2010) JM Jamontt et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cannabidiol improves brain and liver function in a fulminant hepatic failure-induced model of hepatic encephalopathy in mice
- (2010) Y Avraham et al. BRITISH JOURNAL OF PHARMACOLOGY
- Effects of cannabinoids and cannabinoid-enrichedCannabisextracts on TRP channels and endocannabinoid metabolic enzymes
- (2010) Luciano De Petrocellis et al. BRITISH JOURNAL OF PHARMACOLOGY
- Beneficial paracrine effects of cannabinoid receptor 2 on liver injury and regeneration
- (2010) Fatima Teixeira-Clerc et al. HEPATOLOGY
- Cannabidiol Attenuates Cardiac Dysfunction, Oxidative Stress, Fibrosis, and Inflammatory and Cell Death Signaling Pathways in Diabetic Cardiomyopathy
- (2010) Mohanraj Rajesh et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Antidepressant-like effects of cannabidiol in mice: possible involvement of 5-HT1A receptors
- (2009) TV Zanelati et al. BRITISH JOURNAL OF PHARMACOLOGY
- Alcoholic liver disease
- (2009) Robert S. O'Shea et al. HEPATOLOGY
- Cannabinoid activation of peroxisome proliferator-activated receptors: Potential for modulation of inflammatory disease
- (2009) S.E. O'Sullivan et al. IMMUNOBIOLOGY
- Cannabidiol ameliorates cognitive and motor impairments in mice with bile duct ligation
- (2009) Iddo Magen et al. JOURNAL OF HEPATOLOGY
- Cannabidiol Targets Mitochondria to Regulate Intracellular Ca2+ Levels
- (2009) D. Ryan et al. JOURNAL OF NEUROSCIENCE
- The neuroprotective effect of cannabidiol in an in vitro model of newborn hypoxic–ischemic brain damage in mice is mediated by CB2 and adenosine receptors
- (2009) A. Castillo et al. NEUROBIOLOGY OF DISEASE
- Evidence for a potential role for TRPV1 receptors in the dorsolateral periaqueductal gray in the attenuation of the anxiolytic effects of cannabinoids
- (2009) Alline Cristina Campos et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Inhibition of Recombinant Human T-type Calcium Channels by Δ9-Tetrahydrocannabinol and Cannabidiol
- (2008) Hamish Redmond Ross et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Effect of cannabidiol on sepsis-induced motility disturbances in mice: involvement of CB1receptors and fatty acid amide hydrolase
- (2008) d. de filippis et al. NEUROGASTROENTEROLOGY AND MOTILITY
- CB2 receptors as new therapeutic targets for liver diseases
- (2007) S Lotersztajn et al. BRITISH JOURNAL OF PHARMACOLOGY
- The diverse CB1and CB2receptor pharmacology of three plant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin
- (2007) R G Pertwee BRITISH JOURNAL OF PHARMACOLOGY
- The orphan receptor GPR55 is a novel cannabinoid receptor
- (2007) E Ryberg et al. BRITISH JOURNAL OF PHARMACOLOGY
- 5-Lipoxygenase and anandamide hydrolase (FAAH) mediate the antitumor activity of cannabidiol, a non-psychoactive cannabinoid
- (2007) P. Massi et al. JOURNAL OF NEUROCHEMISTRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now